 The purpose of this study is to evaluate how much and how fast a single, oral, daily 25 mg dose of TMC278 is absorbed into the body when administered as a solution, suspension, granules, or a tablet. In addition, the effect of each formulation of TMC278 will be evaluated in patients in the fasted and fed states and the palatability how the drug tastes of each formulation will be assessed. Finally, the safety and tolerability of each formulation of TMC278 will be assessed throughout the study. 